MEDI 312-Discovery of YM155, a novel survivin suppressant for the treatment of cancer

被引：0
|
作者：
Kinoyama, Isao [1 ]
Matsuhisa, Akira [1 ]
Nakahara, Takahito [1 ]
Takeuchi, Masahiro [1 ]
Shirasuna, Kenna [1 ]
Minematsu, Tsuyoshi [1 ]
Asai, Norio [1 ]
Matsumoto, Shunichiro [1 ]
Kawaguchi, Kenichi [1 ]
Kazami, Junichi [1 ]
Toyoshima, Akira [1 ]
Kita, Aya [1 ]
Tominaga, Fumiko [1 ]
Okada, Minoru [1 ]
Ohta, Mitsuaki [1 ]
机构：
[1] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 234卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
312-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Survivin and YM155: How faithful is the liaison?
    Rauch, Anke
    Hennig, Dorle
    Schaefer, Claudia
    Wirth, Matthias
    Marx, Christian
    Heinzel, Thorsten
    Schneider, Guenter
    Kraemer, Oliver H.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1845 (02): : 202 - 220
  • [22] Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
    T Iwasa
    I Okamoto
    K Takezawa
    K Yamanaka
    T Nakahara
    A Kita
    H Koutoku
    M Sasamata
    E Hatashita
    Y Yamada
    K Kuwata
    M Fukuoka
    K Nakagawa
    British Journal of Cancer, 2010, 103 : 36 - 42
  • [23] Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs
    Iwasa, T.
    Okamoto, I.
    Takezawa, K.
    Yamanaka, K.
    Nakahara, T.
    Kita, A.
    Koutoku, H.
    Sasamata, M.
    Hatashita, E.
    Yamada, Y.
    Kuwata, K.
    Fukuoka, M.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2010, 103 (01) : 36 - 42
  • [24] The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2
    Yoon, Dok Hyun
    Shin, Jae-Sik
    Jin, Dong-Hoon
    Hong, Seung-Woo
    Jung, Kyung A.
    Kim, Seung-Mi
    Hong, Yong Sang
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Suh, Cheolwon
    Lee, Jung Shin
    Kim, Tae Won
    ANTICANCER RESEARCH, 2012, 32 (05) : 1681 - 1688
  • [25] Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
    Iwasa, Tsutomu
    Okamoto, Isamu
    Suzuki, Minoru
    Nakahara, Takahito
    Yamanaka, Kentaro
    Hatashita, Erina
    Yamada, Yuki
    Fukuoka, Masahiro
    Ono, Koji
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6496 - 6504
  • [26] YM155 reverses rapamycin resistance in renal cancer by decreasing survivin
    Koike, Hidekazu
    Nitta, Takashi
    Sekine, Yoshitaka
    Arai, Seiji
    Furuya, Yosuke
    Nomura, Masashi
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Oyama, Tetsunari
    Suzuki, Kazuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (10) : 1705 - 1713
  • [27] YM155, a novel survivin suppressant, induced downregulation of survivin and potent antitumor activities in experimental human prostate tumor xenograft models.
    Nakahara, T
    Takeuchi, M
    Isao, K
    Tsuyoshi, M
    Akira, M
    Kita, A
    Tominaga, F
    Yamanaka, K
    Sasamata, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9082S - 9083S
  • [28] DECREASING SURVIVIN BY YM155 REVERSES RAPAMYCIN RESISTANCE IN RENAL CANCER
    Koike, Hidekazu
    Nitta, Takashi
    Sekine, Yoshitaka
    Miyazawa, Yoshiyuki
    Kato, Haruo
    Furuya, Yosuke
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2015, 193 (04): : E458 - E458
  • [29] DECREASING SURVIVIN BY YM155 REVERSES CABAZITAXEL RESISTANCE IN PROSTATE CANCER
    Miyao, Takeshi
    Koike, Hidekazu
    Otsu, Akira
    Oka, Daisuke
    Aoki, Masanori
    Nakayama, Hiroshi
    Miyazawa, Yoshiyuki
    Arai, Seiji
    Sekine, Yoshitaka
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2020, 203 : E770 - E770
  • [30] YM155 reverses rapamycin resistance in renal cancer by decreasing survivin
    Hidekazu Koike
    Takashi Nitta
    Yoshitaka Sekine
    Seiji Arai
    Yosuke Furuya
    Masashi Nomura
    Hiroshi Matsui
    Yasuhiro Shibata
    Kazuto Ito
    Tetsunari Oyama
    Kazuhiro Suzuki
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1705 - 1713
12345